The ESTRO Breur lecture 2009. from population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer

Radiotherapy and Oncology

Volumn 96, Issue 2, 2010, Pages 145-152

  Lambin, Philippe ^a   Petit, Steven F ^a   Aerts, Hugo J W L ^a   Van Elmpt, Wouter J C ^a   Oberije, Cary J G ^a   Starmans, Maud H W ^a   Van Stiphout, Ruud G P M ^a   Van Dongen, Guus A M S ^b   Muylle, Kristoff ^c   Flamen, Patrick ^c   Dekker, André L A J ^a   De Ruysscher, Dirk ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JULES BORDET INSTITUTE   (Belgium)

Author keywords

Biological dose optimization; Dose redistribution; Dose painting; Fluorodeoxyglucose (FDG); Heterogeneity; Non small cell lung cancer (NSCLC)

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; RITUXIMAB ZR 89; UNCLASSIFIED DRUG;

CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; CONFERENCE PAPER; DECISION SUPPORT SYSTEM; HUMAN; IMAGE QUALITY; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; QUALITY CONTROL; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING; TUMOR VOLUME; VOXEL BASED MORPHOMETRY;

EID: 77955709497     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.07.001     Document Type: Conference Paper

References (89)

1. C.W. Hurkmans, J.P. Cuijpers, and F.J. Lagerwaard Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study Radiat Oncol 4 2009 1
2. J.F. Fowler, W.A. Tome, J.D. Fenwick, and M.P. Mehta A challenge to traditional radiation oncology Int J Radiat Oncol Biol Phys 60 2004 1241 1256
3. A. van Baardwijk, G. Bosmans, and S.M. Bentzen Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial Int J Radiat Oncol Biol Phys 71 2008 1103 1110
4. A. van Baardwijk, S. Wanders, and L. Boersma Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer J Clin Oncol 28 2010 1380 1386
5. F.K. Chun, P.I. Karakiewicz, and A. Briganti Prostate cancer nomograms: an update Eur Urol 50 2006 914 926 [discussion 926]
6. R. Valdagni, T. Rancati, and C. Fiorino Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT Int J Radiat Oncol Biol Phys 71 2008 1065 1073
7. J.D. Bradley, A. Hope, and I. El Naqa A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data Int J Radiat Oncol Biol Phys 69 2007 985 992
8. C. Dehing-Oberije, S. Yu, and D. De Ruysscher Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy Int J Radiat Oncol Biol Phys 74 2009 355 362
9. W.P. Smith, J. Doctor, J. Meyer, I.J. Kalet, and M.H. Phillips A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov model Artif Intell Med 46 2009 119 130
10. M.K. Martel, R.K. Ten Haken, and M.B. Hazuka Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1999 31 37
11. S.L. Kwa, J.V. Lebesque, and J.C. Theuws Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients Int J Radiat Oncol Biol Phys 42 1998 1 9
12. S.M. Bentzen Theragnostic imaging for radiation oncology: dose-painting by numbers Lancet Oncol 6 2005 112 117
13. A.R. Padhani, K.A. Krohn, J.S. Lewis, and M. Alber Imaging oxygenation of human tumours Eur Radiol 17 2007 861 872
14. R. Alonzi, and P. Hoskin Functional imaging in clinical oncology: magnetic resonance imaging- and computerised tomography-based techniques Clin Oncol (R Coll Radiol) 18 2006 555 570
15. H.J. Aerts, A.A. van Baardwijk, and S.F. Petit Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 2009 386 392
16. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560
17. E. Malinen, A. Sovik, D. Hristov, O.S. Bruland, and D.R. Olsen Adapting radiotherapy to hypoxic tumours Phys Med Biol 51 2006 4903 4921
18. A. Sovik, E. Malinen, O.S. Bruland, S.M. Bentzen, and D.R. Olsen Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study Phys Med Biol 52 2007 499 513
19. M. Alber, F. Paulsen, S.M. Eschmann, and H.J. Machulla On biologically conformal boost dose optimization Phys Med Biol 48 2003 N31 N35
20. D. Thorwarth, S.M. Eschmann, F. Paulsen, and M. Alber Hypoxia dose painting by numbers: a planning study Int J Radiat Oncol Biol Phys 68 2007 291 300
21. Y. Yang, and L. Xing Towards biologically conformal radiation therapy (BCRT): selective IMRT dose escalation under the guidance of spatial biology distribution Med Phys 32 2005 1473 1484
22. K.S. Chao, W.R. Bosch, and S. Mutic A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 49 2001 1171 1182
23. S.F. Petit, H.J. Aerts, and J.G. van Loon Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study Radiother Oncol 91 2009 393 398
24. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res 49 1989 6449 6465
25. D.M. Brizel, G.S. Sibley, L.R. Prosnitz, R.L. Scher, and M.W. Dewhirst Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38 1997 285 289
26. M.G. Magagnin, M. Koritzinsky, and B.G. Wouters Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies Drug Resist Updat 9 2006 185 197
27. B.G. Wouters, and J.M. Brown Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy Radiat Res 147 1997 541 550
28. S.F. Petit, A.L. Dekker, and R. Seigneuric Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study Phys Med Biol 54 2009 2179 2196
29. J.S. Rasey, Z. Grunbaum, and S. Magee Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells Radiat Res 111 1987 292 304
30. 2 electrode measurements. Influence of tumour volume and carbogen breathing Acta Oncol 41 2002 304 312
31. J.G. Rajendran, D.L. Schwartz, and J. O'Sullivan Tumor hypoxia imaging with [F-18]fluoromisonidazole positron emission tomography in head and neck cancer Clin Cancer Res 12 2006 5435 5441
32. M. Zimny, B. Gagel, and E. Dimartino FDG-a marker of tumour hypoxia? A comparison with [(18)F]fluoromisonidazole and pO (2)-polarography in metastatic head and neck cancer Eur J Nucl Med Mol Imaging 33 2006 1426 1431
33. S.M. Eschmann, F. Paulsen, and M. Reimold Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy J Nucl Med 46 2005 253 260
34. A. Laprie, I. Catalaa, and E. Cassol Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study Int J Radiat Oncol Biol Phys 70 2008 773 781
35. A. Abramyuk, S. Tokalov, and K. Zophel Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? Radiother Oncol 91 2009 399 404
36. H.J. Aerts, G. Bosmans, and A.A. van Baardwijk Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study Int J Radiat Oncol Biol Phys 71 2008 1402 1407
37. C. Schutze, R. Bergmann, and A. Yaromina Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice Radiother Oncol 83 2007 311 315
38. A. van Baardwijk, G. Bosmans, and R.J. van Suylen Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study Radiother Oncol 87 2008 55 58
39. C. Gillham, D. Zips, and F. Ponisch Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? Radiother Oncol 88 2008 335 341
40. H.J. Aerts, L. Dubois, and L. Perk Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET J Nucl Med 50 2009 123 131
41. K. Muylle, D.J. Vugts, and N. Meuleman Diagnostic accuracy of 89Zr-rituximab-PET/CT imaging in patients with relapsed CD20+ B-cell non-Hodgkin's lymphoma: comparison with 18FDG-PET Eur J Nucl Med Mol Imaging 36 2009 OP424 [abstract]
42. A.L. Grosu, M. Souvatzoglou, and B. Roper Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer Int J Radiat Oncol Biol Phys 69 2007 541 551
43. G.P. Chen, E. Ahunbay, C. Schultz, and X.A. Li Development of an inverse optimization package to plan nonuniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images Med Phys 34 2007 1198 1205
44. G. Rodrigues, M. Lock, D. D'Souza, E. Yu, and J. Van Dyk Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer - a systematic review Radiother Oncol 71 2004 127 138
45. E.J. van Beek, and E.A. Hoffman Functional imaging: CT and MRI Clin Chest Med 29 2008 195 216 vii
46. M. Eichinger, R. Tetzlaff, M. Puderbach, N. Woodhouse, and H.U. Kauczor Proton magnetic resonance imaging for assessment of lung function and respiratory dynamics Eur J Radiol 64 2007 329 334
47. R.H. Ireland, C.M. Bragg, and M. McJury Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 68 2007 273 281
48. B.A. Simon Non-invasive imaging of regional lung function using X-ray computed tomography J Clin Monit Comput 16 2000 433 442
49. T. Guerrero, K. Sanders, and E. Castillo Dynamic ventilation imaging from four-dimensional computed tomography Phys Med Biol 51 2006 777 791
50. T. Guerrero, K. Sanders, and J. Noyola-Martinez Quantification of regional ventilation from treatment planning CT Int J Radiat Oncol Biol Phys 62 2005 630 634
51. B.P. Yaremko, T.M. Guerrero, and J. Noyola-Martinez Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance Int J Radiat Oncol Biol Phys 68 2007 562 571
52. Y. Seppenwoolde, S.H. Muller, and J.C. Theuws Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer Int J Radiat Oncol Biol Phys 47 2000 681 690
53. L.B. Marks, D.P. Spencer, and G.C. Bentel The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation Int J Radiat Oncol Biol Phys 26 1993 659 668
54. K. Lavrenkov, J.A. Christian, and M. Partridge A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer Radiother Oncol 83 2007 156 162
55. Y. Seppenwoolde, M. Engelsman, and K. De Jaeger Optimizing radiation treatment plans for lung cancer using lung perfusion information Radiother Oncol 63 2002 165 177
56. S.M. McGuire, L.B. Marks, F.F. Yin, and S.K. Das A methodology for selecting the beam arrangement to reduce the intensity-modulated radiation therapy (IMRT) dose to the SPECT-defined functioning lung Phys Med Biol 55 2010 403 416
57. A. Alavi, N. Gupta, and J.L. Alberini Positron emission tomography imaging in nonmalignant thoracic disorders Semin Nucl Med 32 2002 293 321
58. J.P. Hart, M.R. McCurdy, and M. Ezhil Radiation pneumonitis: correlation of toxicity with pulmonary metabolic radiation response Int J Radiat Oncol Biol Phys 71 2008 967 971
59. D. De Ruysscher, A. Houben, and H.J. Aerts Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study Radiother Oncol 91 2009 415 420
60. Petit S, Elmpt v, Dehing-Oberije. 18F-fluorodeoxyglucose uptake patterns in the lung before radiotherapy identify areas that are more susceptible to radiation-induced lung toxicity in non-small cell lung cancer patients. Int J Radiat Oncol Biol Phys 2010; doi:10.1016/j.jirobp.2010.06.016.
61. A. Sovik, E. Malinen, H.K. Skogmo, S.M. Bentzen, O.S. Bruland, and D.R. Olsen Radiotherapy adapted to spatial and temporal variability in tumor hypoxia Int J Radiat Oncol Biol Phys 68 2007 1496 1504
62. B. Vanderstraeten, W. Duthoy, W. De Gersem, W. De Neve, and H. Thierens [18F]Fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer Radiother Oncol 79 2006 249 258
63. A. Sovik, E. Malinen, and D.R. Olsen Strategies for biologic image-guided dose escalation: a review Int J Radiat Oncol Biol Phys 73 2009 650 658
64. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
65. Y. Shioyama, S.Y. Jang, and H.H. Liu Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 68 2007 1349 1358
66. S. Das A role for biological optimization within the current treatment planning paradigm Med Phys 36 2009 4672 4682
67. S.K. Das, M.M. Miften, and S. Zhou Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions Med Phys 31 2004 1452 1461
68. E. Heath, J. Unkelbach, and U. Oelfke Incorporating uncertainties in respiratory motion into 4D treatment plan optimization Med Phys 36 2009 3059 3071
69. M.G. Witte, J. van der Geer, C. Schneider, J.V. Lebesque, M. Alber, and M. van Herk IMRT optimization including random and systematic geometric errors based on the expectation of TCP and NTCP Med Phys 34 2007 3544 3555
70. W. van Elmpt, L. McDermott, S. Nijsten, M. Wendling, P. Lambin, and B. Mijnheer A literature review of electronic portal imaging for radiotherapy dosimetry Radiother Oncol 88 2008 289 309
71. S.M. Nijsten, W.J. van Elmpt, and B.J. Mijnheer Prediction of DVH parameter changes due to setup errors for breast cancer treatment based on 2D portal dosimetry Med Phys 36 2009 83 94
72. L.N. McDermott, M. Wendling, J.J. Sonke, M. van Herk, and B.J. Mijnheer Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT Int J Radiat Oncol Biol Phys 67 2007 1568 1577
73. W.D. Renner 3D dose reconstruction to insure correct external beam treatment of patients Med Dosim 32 2007 157 165
74. A. Van Esch, T. Depuydt, and D.P. Huyskens The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification of dynamic IMRT fields Radiother Oncol 71 2004 223 234
75. M. Wendling, L.N. McDermott, A. Mans, J.J. Sonke, M. van Herk, and B.J. Mijnheer A simple backprojection algorithm for 3D in vivo EPID dosimetry of IMRT treatments Med Phys 36 2009 3310 3321
76. S.F. Petit, W.J. van Elmpt, P. Lambin, and A.L. Dekker Dose recalculation in megavoltage cone-beam CT for treatment evaluation: removal of cupping and truncation artefacts in scans of the thorax and abdomen Radiother Oncol 94 2010 359 366
77. W. van Elmpt, S. Petit, D. De Ruysscher, P. Lambin, and A. Dekker 3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer Radiother Oncol 94 2010 188 194
78. J. Chen, O. Morin, M. Aubin, M.K. Bucci, C.F. Chuang, and J. Pouliot Dose-guided radiation therapy with megavoltage cone-beam CT Br J Radiol 79 Spec. No. 1 2006 S87 S98
79. M. Partridge, M. Ebert, and B.M. Hesse IMRT verification by three-dimensional dose reconstruction from portal beam measurements Med Phys 29 2002 1847 1858
80. L.N. McDermott, M. Wendling, and J. Nijkamp 3D in vivo dose verification of entire hypo-fractionated IMRT treatments using an EPID and cone-beam CT Radiother Oncol 86 2008 35 42
81. M. van Zijtveld, M. Dirkx, and B. Heijmen Correction of conebeam CT values using a planning CT for derivation of the "dose of the day" Radiother Oncol 85 2007 195 200
82. W. van Elmpt, S. Nijsten, S. Petit, B. Mijnheer, P. Lambin, and A. Dekker 3D in vivo dosimetry using megavoltage cone-beam CT and EPID dosimetry Int J Radiat Oncol Biol Phys 73 2009 1580 1587
83. G. Bosmans, A. van Baardwijk, and A. Dekker Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study Int J Radiat Oncol Biol Phys 66 2006 748 753
84. J.J. Sonke, J. Lebesque, and M. van Herk Variability of four-dimensional computed tomography patient models Int J Radiat Oncol Biol Phys 70 2008 590 598
85. van Elmpt W, Öllers M, van Herwijnen H, et al. Volume or position changes of the primary lung tumor during (chemo-)radiotherapy cannot be used as a surrogate for the mediastinal lymph node changes: the case for optimal mediastinal lymph node imaging during radiotherapy. Int J Radiat Oncol Biol Phys; doi:10.1016/j.ijrobp.2009.10.059.
86. Verellen D, De Ridder M, Storme G. A (short) history of image-guided radiotherapy. Radiother Oncol 2008;86:4-13.
87. Woodford C, Yartsev S, Dar AR, Bauman G, Van Dyk J. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys 2007;69:1316-22.
88. Harsolia A, Hugo GD, Kestin LL, Grills IS, Yan D. Dosimetric advantages of fourdimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography. Int J Radiat Oncol Biol Phys 2008;70:582-9.
89. Ahunbay EE, Peng C, Chen GP, et al. An on-line replanning scheme for interfractional variations. Med Phys 2008;35:3607-15.